financetom
Business
financetom
/
Business
/
Bloomin' Brands Invests For Longer-Term Growth, Will Do 'Fewer Things Better'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bloomin' Brands Invests For Longer-Term Growth, Will Do 'Fewer Things Better'
May 26, 2025 6:01 AM

Shares of Bloomin’ Brands Inc.  climbed in early Monday trading despite the company reporting a decline in first-quarter sales on Friday.

CEO Mike Spanos is identifying various investments that are "necessary for the longer-term vitality" of the company's different businesses, according to JPMorgan. 

The Bloomin’ Brands Analyst: Analyst John Ivankoe maintained a Neutral rating and price target of $9.

The Bloomin’ Brands Thesis: While the estimates for fiscal 2026 and 2027 reflect significant reinvestment, not all of this may be needed to "recapture lost share from peers," Ivankoe said in the note.

Check out other analyst stock ratings.

"The ongoing multi-market 14-store test is trying to assess the level of investment needed to drive traffic such as menu work (creating new menu items at a lower cost), making things easier and creating a more appealing environment," the analyst wrote.

While Bloomin’ Brands aims to further simplify its menu, with the aim of doing "fewer things better," it recognizes Outback's variety of items drives incremental traffic, he added.

Management's second-quarter comp guidance of -2.5% to -1.5% reflects the "continuation of a choppy macro and cautious consumer," Ivankoe stated.

BLMN Price Action: At the time of publication on Monday, shares of Bloomin’ Brands had risen by 14.18% to $8.34.

Read More: Bloomin’ Brands Stock Drops on Weak Guidance and Demand Concerns

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coya Therapeutics Shares Fall After Phase 2 Alzheimer's Disease Study Results
Coya Therapeutics Shares Fall After Phase 2 Alzheimer's Disease Study Results
Nov 3, 2024
12:20 PM EDT, 10/29/2024 (MT Newswires) -- Coya Therapeutics ( COYA ) shares fell nearly 23% in recent Tuesday trading after the company reported results from its phase 2 trial of LD IL-2 in patients with mild to moderate Alzheimer's Disease. The placebo-controlled study evaluated two dosing regimens of subcutaneous low-dose interleukin-2, or IL-2. The trial met its primary and...
Cognizant Selected as Alnylam's IT Services Provider
Cognizant Selected as Alnylam's IT Services Provider
Nov 3, 2024
12:25 PM EDT, 10/29/2024 (MT Newswires) -- Cognizant Technology Solutions ( CTSH ) said Tuesday it was selected to become Alnylam Pharmaceuticals' ( ALNY ) IT managed services provider. Cognizant said it would be responsible for managing Alnylam's global infrastructure and operations, cloud, security, platforms, applications, and advanced data analytics. The company did not disclose the financial terms of the...
Lucid Group to Begin US Orders for Lucid Gravity SUV on Nov. 7
Lucid Group to Begin US Orders for Lucid Gravity SUV on Nov. 7
Nov 3, 2024
12:35 PM EDT, 10/29/2024 (MT Newswires) -- Lucid Group ( LCID ) said Tuesday it will start taking orders in the US for the Lucid Gravity SUV on Nov. 7. Orders will open initially for the Grand Touring variant, starting at $94,900, with production set to begin in late 2024, the electric vehicle maker said. The production of the Gravity...
Soccer-Amorim set to be new Man Utd boss as Sporting confirm interest
Soccer-Amorim set to be new Man Utd boss as Sporting confirm interest
Nov 3, 2024
Oct 29 (Reuters) - Ruben Amorim is set to become the next manager of Manchester United ( MANU ) with the Premier League club prepared to pay Sporting the 10 million euros ($10.79 million) release clause, the Portuguese club said on Tuesday. The news comes a day after the team sacked Erik ten Hag with United languishing in 14th place...
Copyright 2023-2025 - www.financetom.com All Rights Reserved